Gilead Sciences, Inc. (GILD) Stock Overview
Explore Gilead Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Gilead Sciences, Inc. (GILD)
Key Financials
Key Financials
Market Cap
158.8B
P/E Ratio
16.93
EPS (TTM)
$8.37
ROE
0.42%
GILD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Gilead Sciences, Inc. (GILD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 49.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $161.77.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.93 and a market capitalization of 158.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.